Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Heyn

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Nature|November 9, 2022
Metastatic recurrence in colorectal cancer arises from residual EMP1<sup>+</sup> cellsAdrià Cañellas-Socias, Carme Cortina, Xavier Hernando-Momblona, et al.
Hemasphere|March 4, 2024
Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cellsTalia Velasco-Hernandez, Juan L Trincado, Meritxell Vinyoles, et al.
Cell Research|June 1, 2016
RANKL/RANK control Brca1 mutation- Verena Sigl, Kwadwo Owusu-Boaitey, Purna A Joshi, et al.
The Lancet. Oncology|August 31, 2016
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysisSebastian Moran, Anna Martínez-Cardús, Sergi Sayols, et al.
Cancer Research|March 11, 2025
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Breast CancerFlaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, et al.
Nature Metabolism|August 10, 2023
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapyMarta Redondo-Muñoz, Francisco Javier Rodriguez-Baena, Paula Aldaz, et al.
Nature Medicine|June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFRMiguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
Brain : a Journal of Neurology|July 24, 2024
Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progressionAlexandra Monceau, Rasya Gokul Nath, Xavier Suárez-Calvet, et al.
Cell|July 12, 2016
A Landscape of Pharmacogenomic Interactions in CancerFrancesco Iorio, Theo A Knijnenburg, Daniel J Vis, et al.
Nature Biotechnology|June 11, 2020
Benchmarking single-cell RNA-sequencing protocols for cell atlas projectsElisabetta Mereu, Atefeh Lafzi, Catia Moutinho, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Nature|November 9, 2022
Metastatic recurrence in colorectal cancer arises from residual EMP1<sup>+</sup> cellsAdrià Cañellas-Socias, Carme Cortina, Xavier Hernando-Momblona, et al.
Hemasphere|March 4, 2024
Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cellsTalia Velasco-Hernandez, Juan L Trincado, Meritxell Vinyoles, et al.
Cell Research|June 1, 2016
RANKL/RANK control Brca1 mutation- Verena Sigl, Kwadwo Owusu-Boaitey, Purna A Joshi, et al.
The Lancet. Oncology|August 31, 2016
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysisSebastian Moran, Anna Martínez-Cardús, Sergi Sayols, et al.
Cancer Research|March 11, 2025
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Breast CancerFlaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, et al.
Nature Metabolism|August 10, 2023
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapyMarta Redondo-Muñoz, Francisco Javier Rodriguez-Baena, Paula Aldaz, et al.
Nature Medicine|June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFRMiguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
Brain : a Journal of Neurology|July 24, 2024
Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progressionAlexandra Monceau, Rasya Gokul Nath, Xavier Suárez-Calvet, et al.
Cell|July 12, 2016
A Landscape of Pharmacogenomic Interactions in CancerFrancesco Iorio, Theo A Knijnenburg, Daniel J Vis, et al.
Nature Biotechnology|June 11, 2020
Benchmarking single-cell RNA-sequencing protocols for cell atlas projectsElisabetta Mereu, Atefeh Lafzi, Catia Moutinho, et al.
Pageof 14